Details for New Drug Application (NDA): 215421
NDA 215421 describes LIRAGLUTIDE, which is a drug marketed by Biocon Pharma, Fresenius Kabi Usa, Hikma, Lupin, Mylan Institutional, Nanjing King Friend, Orbicular, Sandoz, and Teva Pharms, and is included in eleven NDAs. It is available from ten suppliers. Additional details are available on the LIRAGLUTIDE profile page.
The generic ingredient in LIRAGLUTIDE is liraglutide. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the liraglutide profile page.
The generic ingredient in LIRAGLUTIDE is liraglutide. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the liraglutide profile page.
Summary for 215421
| Tradename: | LIRAGLUTIDE |
| Applicant: | Lupin |
| Ingredient: | liraglutide |
| Patents: | 0 |
Pharmacology for NDA: 215421
| Mechanism of Action | Glucagon-like Peptide-1 (GLP-1) Agonists |
Suppliers and Packaging for NDA: 215421
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LIRAGLUTIDE | liraglutide | SOLUTION;SUBCUTANEOUS | 215421 | ANDA | Lupin Pharmaceuticals, Inc. | 70748-346 | 70748-346-02 | 2 SYRINGE, PLASTIC in 1 CARTON (70748-346-02) / 3 mL in 1 SYRINGE, PLASTIC |
| LIRAGLUTIDE | liraglutide | SOLUTION;SUBCUTANEOUS | 215421 | ANDA | Lupin Pharmaceuticals, Inc. | 70748-346 | 70748-346-03 | 3 SYRINGE, PLASTIC in 1 CARTON (70748-346-03) / 3 mL in 1 SYRINGE, PLASTIC |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;SUBCUTANEOUS | Strength | 18MG/3ML (6MG/ML) | ||||
| Approval Date: | Jul 22, 2025 | TE: | AP1 | RLD: | No | ||||
Complete Access Available with Subscription
